Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Biosurgery Market worth $16.0 ...

After hours: January 24 at 4:01:27 PM EST Loading Chart for OFIX ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

U.S. aging population and lifestyle factors drive demand for spinal surgeries. Advanced graft technologies and strong healthcare reimbursement fuel market.

The global bone growth products market size was valued at USD 1.29 billion in 2024 and is projected to reach from USD 1.34 ...

JPMorgan Chase & Co. lifted its stake in Sprott Physical Silver Trust (NYSEARCA:PSLV – Free Report) by 16.8% during the third quarter, according to the company in its most recent Form 13F filing with ...